The FDA approved a new generic abortion pill, drawing swift condemnation from anti-abortion conservatives.
Federal regulators have approved a new generic version of the abortion pill mifepristone, prompting immediate criticism from anti-abortion groups and conservative politicians.
Drugmaker Evita Solutions announced that the U.S. Food and Drug Administration had authorized its low-cost version of the pill, which is used to terminate pregnancies up to 10 weeks.
Students for Life Action condemned the move as “a stain on the Trump presidency,” while Republican Senator Josh Hawley declared he had “lost confidence in the leadership at FDA.”
The backlash comes as President Donald Trump’s health officials, including Health Secretary Robert F. Kennedy Jr., face rising pressure from abortion opponents to reevaluate mifepristone’s approval.
In a recent letter to Republican attorneys general, Kennedy and FDA Commissioner Dr. Marty Makary pledged to conduct a full safety review.
Mifepristone, approved in 2000, is typically used with misoprostol and now accounts for two-thirds of U.S. abortions. Access remains restricted in several states with abortion bans.